April 10, 2020
Home | Contact Glen | LinksMedia || Privacy Statement || Disclaimer | Canada | Saskatchewan   

Legislative Report
(20 October 2010)

Keeping Our Promise on MS

Our government is continuing to put patients first. We are committing $5 million to fund clinical trials for the Multiple Sclerosis (MS) liberation therapy. The procedure is a potentially ground-breaking treatment for MS and this funding will help determine its validity. The $5-million dollars will go to the Saskatchewan Health Research Foundation (SHRF). The SHRF will establish an advisory panel, develop the call for clinical trials, and provide the scientific, ethical, and financial expertise to manage this initiative. With the leadership and assistance of the SHRF, any clinical trials undertaken will proceed based on the best expertise science can offer.

Saskatchewan MS patients and their families will play an important part in the clinical trials. Information about how interested patients may take part will be available after a research team has been announced in 2011. Patients are then encouraged to watch for updates and announcements. The goal is to have a process in place for proceeding with clinical trials by the spring of 2011. More information will be posted on the SHRF website.

By taking a leadership role on this important health issue, it will bring us that much closer to finding the important answers our patients, and their families, need and deserve. We hope this research will have a positive affect for many people right here in Saskatchewan and across the country.

If you have a question about this Legislative Report or any other matter, just Contact Glen.

Past Legislative Reports

Generation v2.54 Site design ©2020 Kontakt Consulting. Web-Hosting by Metric-Hosting Ltd.

All contents are ©2020 Glen Hart MLA, Last Mountain - Touchwood.

This site is best viewed with a resolution set to at least 800x600 using Internet Explorer 6 or higher.